NCT05285189

Brief Summary

Benign hypertrophy of the prostate (BPH) is a disease seen in 20% of men over the age of 50 and in 40% of those over the age of 70. The gold standard in the treatment of BPH is transurethral resection of the prostate using high-frequency diathermy. Today, this process is done with the bipolar technique, in which isotonic saline (isotonic sodium chloride %0.9) is used as the irrigation fluid. This irrigation fluid, which is used after long operation and deep tissue resection, can enter the systemic circulation through the opened venous sinuses. It has been shown in clinical studies that postoperative acute hyperchloremia (serum Cl level \> 110 mmol/L) develops after the use of intravenous normal saline solution in large amounts in the perioperative period. Our aim is to detect hyperchloremia and associated metabolic acidosis without anion gap in the follow-up of these patients. Our primary hypothesis in this study is that hyperchloremic metabolic acidosis will develop due to the high amount of normal saline used in TUR-P. .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

3.6 years

First QC Date

March 9, 2022

Last Update Submit

March 16, 2022

Conditions

Keywords

Blood gas analysisTUR-PIrrigation FluidHyperchloremia

Outcome Measures

Primary Outcomes (1)

  • Serum Chlorid level

    Chlorid level is evaluated with blood gas analysis 3 times in total, at the beginning of the operation, at the 40th minute of the operation and 1st hour of arrival in post-anesthesia care unit.

    Up to 4 hours

Secondary Outcomes (11)

  • Serum anion gap level

    Up to 4 hours

  • Serum lactate level

    Up to 4 hours

  • Presence&absence of capsule perforation during the operation

    Up to 4 hours

  • Amount of prostate tissue resected during the operation

    Up to 4 hours

  • Amount of used normal saline for irrigation during the operation

    Up to 4 hours

  • +6 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsHaving benign prostate hyperplasia
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Male gender who being prostate hyperplasia * Having had a TUR-P operation * Using of bipolar technic * American Society of Anesthesiology (ASA) grade I-III * Receiving patients consent

You may qualify if:

  • Male gender
  • Having had a TUR-P operation
  • Using of bipolar technic
  • American Society of Anesthesiology (ASA) grade I-III
  • Receiving patients consent

You may not qualify if:

  • Failure to record preoperative and postoperative blood gas data
  • Patient refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University

Istanbul, 34093, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Barker ME. 0.9% saline induced hyperchloremic acidosis. J Trauma Nurs. 2015 Mar-Apr;22(2):111-6. doi: 10.1097/JTN.0000000000000115.

  • Dombre V, De Seigneux S, Schiffer E. [Sodium chloride 0.9%: nephrotoxic crystalloid?]. Rev Med Suisse. 2016 Feb 3;12(504):270-2, 274. French.

Study Officials

  • Meltem Savran Karadeniz, Assoc.Prof.

    Istanbul University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sabiha Başarı, MD

CONTACT

Meltem Savran Karadeniz, Assoc.Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof.

Study Record Dates

First Submitted

March 9, 2022

First Posted

March 17, 2022

Study Start

January 1, 2019

Primary Completion

July 29, 2022

Study Completion

July 31, 2022

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations